Ayalon Insurance Company’s VanEck Biotech ETF BBH Stock Holding History

Ayalon Insurance Company’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,000	Closed	-$271K	–	137
2015 Q2	$271K	Sell	2,000 -3,000	-60%	-$399K	0.2%	62
2015 Q1	$648K	Buy	+5,000	New	+$628K	0.4%	53

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

VFAM

Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

LFM

Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return

Ayalon Insurance Company's BBH Position: Q3 2015 in Review

Ayalon Insurance Company sold out of VanEck Biotech ETF (BBH) in Q3 2015, closing a stake of 2,000 shares — an estimated $271K sold.

Ayalon Insurance Company first reported a position in BBH in Q1 2015 and held it in 2 quarters. The position peaked at $648K in Q1 2015. 83 funds tracked by Wall St. Rank hold BBH as of Q3 2015.

Ayalon Insurance Company reported no remaining VanEck Biotech ETF position as of Q3 2015 after selling out during the quarter.
Ayalon Insurance Company sold 2,000 VanEck Biotech ETF shares in Q3 2015, an estimated $271K.
Ayalon Insurance Company first reported a position in VanEck Biotech ETF in Q1 2015 and held it in 2 quarters.
Ayalon Insurance Company's VanEck Biotech ETF position peaked at $648K in Q1 2015.
83 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2015.

Based on Ayalon Insurance Company's 13F filing for Q3 2015, filed 28 Oct 2015.